This approach offers an excellent negative predictive value.1 However, its specificity is poor and there is an increasing ...
Notícias ao Minuto on MSN
Penumbra study backs mechanical thrombectomy for treating pulmonary embolism
The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...
A randomized trial shows greater safety and effectiveness of the large-bore mechanical thrombectomy procedure than the catheter-directed intervention.
Penumbra, Inc. announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum thrombectomy ...
Verywell Health on MSN
8 Common Causes of Shortness of Breath When Walking Short Distances
Shortness of breath when walking short distances can occur suddenly or be a chronic condition. It should be evaluated, as it ...
News-Medical.Net on MSN
Improving diagnosis, treatment and follow-up care for pulmonary embolism
Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year ...
Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy ...
A woman who was in the hospital more than seven months ago and was in a coma for two days is sharing her story of survival ...
Angiodynamics, Inc. (($ANGO)) announced an update on their ongoing clinical study. Study Overview: AngioDynamics, Inc. is conducting a ...
THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE, a prospective, multicenter U.S. study evaluating On-The-Table (OTT) pharmaco-mechanical lysis (PML ...
Meta announced on Tuesday a new Facebook algorithm update that will showcase more Reels videos tailored to users’ preferences. The update includes features that offer users greater control over the ...
The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment. The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results